PILL:NYE-Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF (USD)

ETF | Trading--Leveraged Equity |

Last Closing

USD 8.06

Change

+0.05 (+0.62)%

Market Cap

N/A

Volume

0.05M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-24 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B..

+1.15 (+3.39%)

USD 11.53B
QLD ProShares Ultra QQQ

+0.94 (+0.95%)

USD 6.60B
FNGU MicroSectors FANG+ Index 3X Le..

+5.79 (+1.40%)

USD 5.40B
SSO ProShares Ultra S&P500

+0.51 (+0.57%)

USD 4.93B
UPRO ProShares UltraPro S&P500

+0.72 (+0.85%)

USD 4.05B
TECL Direxion Daily Technology Bull..

+1.62 (+1.94%)

USD 3.15B
USD ProShares Ultra Semiconductors

+5.66 (+5.03%)

USD 1.02B
LABU Direxion Daily S&P Biotech Bul..

-1.83 (-1.40%)

USD 0.99B
DPST Direxion Daily Regional Banks ..

-4.55 (-4.46%)

USD 0.88B
YINN Direxion Daily FTSE China Bull..

+7.38 (+28.98%)

USD 0.76B

ETFs Containing PILL

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.00% 17% F 38% F
Dividend Return 1.00% 67% D+ 22% F
Total Return 5.00% 17% F 31% F
Trailing 12 Months  
Capital Gain 7.61% 14% F 33% F
Dividend Return 1.55% 43% F 23% F
Total Return 9.16% 14% F 28% F
Trailing 5 Years  
Capital Gain -37.42% 25% F 13% F
Dividend Return 2.04% 34% F 6% D-
Total Return -35.38% 25% F 11% F
Average Annual (5 Year Horizon)  
Capital Gain -2.93% 10% F 23% F
Dividend Return -2.45% 10% F 14% F
Total Return 0.48% 37% F 11% F
Risk Return Profile  
Volatility (Standard Deviation) 105.69% 36% F 7% C-
Risk Adjusted Return -2.32% 10% F 23% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.